ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.41
+5.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.12x
- Price / sales
- 1.97x
- Price / cash flow
- 14.47x
Enterprise value
- Enterprise value
- $53.9M
- EV / sales
- 2.53x
- EV / EBITDA
- -6.20x
- EV / EBIT
- -3.97x
- Market cap
- $41.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025